tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
ELVN
Enliven Therapeutics
RESEARCH TOOLSreports

Enliven Therapeutics (ELVN) Stock News & Sentiment

331 Followers
Enliven Therapeutics: Strengthening ELVN-001 Profile and M&A Optionality Support Buy Rating and $56 Price Target
Premium
Ratings
Enliven Therapeutics: Strengthening ELVN-001 Profile and M&A Optionality Support Buy Rating and $56 Price Target
4d ago
ELVN
Leveraging Merck–Terns Benchmark: Supporting Enliven’s ELVN-001 Upside and a Raised $60 Buy Target
Premium
Ratings
Leveraging Merck–Terns Benchmark: Supporting Enliven’s ELVN-001 Upside and a Raised $60 Buy Target
4d ago
ELVN
Enliven Therapeutics: Compelling Early ELVN-001 Data and De-Risked Development Path Support Buy Rating
Premium
Ratings
Enliven Therapeutics: Compelling Early ELVN-001 Data and De-Risked Development Path Support Buy Rating
1M ago
ELVN
Enliven Therapeutics: Compelling ELVN-001 CML Data, Strong Cash Runway Support Buy Rating
Premium
Ratings
Enliven Therapeutics: Compelling ELVN-001 CML Data, Strong Cash Runway Support Buy Rating
1M ago
ELVN
Enliven Therapeutics: Robust ELVN-001 CML Data, Clear Pivotal Path, and Solid Cash Runway Support Buy Rating
Premium
Ratings
Enliven Therapeutics: Robust ELVN-001 CML Data, Clear Pivotal Path, and Solid Cash Runway Support Buy Rating
3M ago
ELVN
Enliven Therapeutics appoints new board chair amid transition
Premium
Company Announcements
Enliven Therapeutics appoints new board chair amid transition
3M ago
8K
ELVN
Enliven Therapeutics Appoints Richard Fair as CEO
Premium
Company Announcements
Enliven Therapeutics Appoints Richard Fair as CEO
4M ago
8K
ELVN
More ELVN News >

ELVN News on the Web

Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)
TipRanks News
Bullish
Why Enliven Therapeutics Stock Is Suddenly Surging
TipRanks News
Bullish
Enliven Therapeutics: Strengthening ELVN-001 Profile and M&A Optionality Support Buy Rating and $56 Price Target
TipRanks News
Bullish
Leveraging Merck–Terns Benchmark: Supporting Enliven’s ELVN-001 Upside and a Raised $60 Buy Target
TipRanks News
Bullish
Why Enliven Therapeutics Stock Is Surging Today
TipRanks News
Bullish
JonesTrading Keeps Their Buy Rating on Enliven Therapeutics (ELVN)
TipRanks News
Neutral
Why Enliven Therapeutics Stock Is Breaking Out Now
TipRanks News
Bullish
Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million
The Motley Fool
Bearish

News Score - Last 7 Days

Very Positive
ELVN
Sector Average
Media Buzz
This Week6 articles
Weekly Average4.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ELVN’s Media Buzz Sentiment?
6 articles about ELVN were published this week. In an average week, 4.75 articles are published.
    What is ELVN’s weekly average amount of articles?
    In an average week, 4.75 articles about ELVN are published.
      What is ELVN’s News Sentiment?
      100% of articles about ELVN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week